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Abstract 
Background: High fat diets are known to cause a positive fat balance and 
consequently to the accumulation of adipose mass. The molecular mechanisms 
underlying the anti-inflammatory activity β-carboline alkaloids E. longifolia, 
which may be useful to prevent or treat diseases of inflammation. Recent studies 
showed that E. longifolia Jack protected HFD animal model from atherosclerosis 
based on the reducing of atherosclerotic plaque size and formation HFD-rats 
treated with E. longifolia Jack. 
Objective: To prove that Eurycoma longifolia has anti inflammatory effect on 
endothelial cell blood vessels of Sprague Dawley rat with high fat diet. 
Method: Study design was experimental study, by used Randomized Post Test 
only Control Group Design with Kruskal-Wallis test to analyzed the differences 
among groups and followed by a Mann Whitney test. Treatment is ethanol or water 
extract of Eurycoma longifolia Jack, and outcome are sICAM-1 and eNOS levels. 
Thirty Sprague Dawley (SD) Rat, were divided into 6 groups. C(-) was SD group, 
C(+) was group with HFD, X1 (SD treated with EL dosage 10 mg/kg), X2 (SD 
treated with EL dosage 15 mg/kg), X3 (HFD treated with EL dosage 10 mg/kg), X4 
(HFD treated with EL dosage 15 mg/kg).  
Result: No significant difference in sICAM-1 that was found among the studied 
groups. sICAM-1 levels of X1 and X2 groups were not different than those of 
negative control group.  No different was observed between sICAM-1 level of X3 
group than positive control group. There is significant difference in eNOS among 
six group studied. The control negative group was not significance different than 
control positive, X2, X3, and X4. X1 showed significant different with negative 
control, X3 and X4. The positive control showed that no significant different than 
X1, X2, X3, and X4. 
Conclusion: Eurycoma longifolia has anti-inflammatory effect especially on 
eNOS of Sprague Dawley rat with high fat diet. 
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INTRODUCTION 
High fat diets are known to cause a positive fat 
balance and consequently to the accumulation of 
adipose mass, this diet does not seem to stimulate fat 
oxidation in the same way in obese and lean subjects1.  
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The HFD increases the level of circulating bad 
cholesterol which boosts the cardiovascular event 
risk. HFD also increases the risks of other diseases 
include diabetes, stroke, and some types of cancers. 
The oxidative stress occurs due to HFD, this is then 
results in hypertension and metabolic disorder2,3.  
HFD also causes obesity which became a worldwide 
epidemic and a major risk factor of several diseases 
including metabolic syndrome.4 Globally, about 39% 
of adults aged 18 years and over were overweight in 
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2014 and 13% of them are clinically obese.5 
Therefore, prevention and treatment of obesity is an 
important factor for a healthy condition. The 
reduction of nutrient digestion and absorption to 
develop inhibitors of the enzyme without altering the 
main mechanisms in the digestive system into the 
most important strategies in the treatment of obesity. 
6,7 
HFD was an inducing factor for intercellular 
adhesion molecule-1 (ICAM-1) expression in the 
aorta of Wistar rats. HFD effect on ICAM-1 seems to 
be time dependent. ICAM-1 is one of the first events 
in the formation of atherosclerotic lesions. 
Additionally, soluble ICAM-1 measurement of the 
concentration in plasma is a reliable index of the 
expression of the molecules in the Wistar rat aorta.8 
Previous studies have found that HFD up-regulated 
Cav-1 and down regulated of eNOS activity in rat 
thoracic aorta; switch to a normal diet is restored 
levels of Cav-1 and eNOS; no change in Cav-1 or 
eNOS expression was observed in DR rats ate a high-
fat diet; high-fat diet increased eNOS (Ser1177) and 
Akt (Ser473) phosphorylation in diet-induced obese 
mice.9 
The use of natural products in health problem now 
become noticeable.10 Eurycoma longifolia Jack 
(Simaroubaceae family) is one of the most popular 
medicinal plants in Southeast Asia, including 
Myanmar, Thailand, Laos, Indonesia, Cambodia, and 
Malaysia.11 Local E. longifolia Jack has many local 
name, for example: Tongkat Ali (in Malaysia), Bidara 
Bitter (in Indonesia) and Cay babinh (in Thailand) 
meaning as a tree that can cure hundreds of diseases.12 
This plant contains quassinoids, squalene derivatives, 
neolignans biphenyl, tricullane-type triterpene, 
canthine-6-one and β-carboline alkaloids. Quassinoid 
is a bitter substance found in Simaroubaceae family 
that has a lot of biological activity as anticancer, anti-
microbial, anti-inflammatory and many other 
protective effect.13 Recent studies showed that E. 
longifolia Jack protected HFD animal model from 
atherosclerosis based on the reduce atherosclerotic 
plaque size and formation HFD-rats treated with E. 
longifolia Jack.14 Similar animal model also showed 
that  E. longifolia Jack reduced levels of triglyceride 
and blood pressure of HFD-rats.15 Antioxidant and 
anti-inflammatory effect of E. longifolia Jack had 
been proven in in vitro study.16 However, it remains 
unknown whether any anti-inflammatory effect of E. 
longifolia Jack involves in the protection of HFD-rats.  
β-carboline alkaloid 7-MCPA (7-methoxy- (9H-β-
carbolin-1-yl) - (E) -1-propenoat acid) isolated from 
E. longifolia hairy root culture Nrf2 is activated via a 
ROS dependent p38 MAPK and 7-MCPA anti-
inflammatory effects associated with activation of 7-
MCPA-induced of Nrf2 / HO-1 pathway. This study 
clarified the molecular mechanisms underlying the 
anti-inflammatory activity of β-carboline alkaloids E. 
longifolia, which may be useful to prevent or treat 
diseases of inflammation.17 Eurycomalactone, 14,15β-
dihydroklaieanone, and 13.21-dehydroeurycomanone 
identified as potent inhibitors of NF-kB with IC50 
values of <1 pM.18 For this study, the mice will be 
treated and given a high-fat diet EL extract from the 
roots as much as 5 mg and 10 mg / kg body weight for 
14 days to determine the levels of sICAM-1 and 
eNOS. 
This research aimed to prove that Eurycoma 
longifolia has anti-inflammatory effect on endothelial 
cell blood vessels of Sprague Dawley rat with high fat 
diet. 
 
MATERIALS AND METHOD  
This study design was experimental study, by used 
randomized post test only control group design. 
Kruskal-Wallis test was used to analyze the 
differences among groups and followed by a Mann 
Whitney test. Population of this study was Sprague 
Dawley (SD) Rat, with inclusion criteria were: male; 
weight 150-200 gram; 8 - 9 weeks of age; and healthy 
indicated by active movement and anatomically 
normal. Thirty Sprague Dawley (SD) Rat, were 
divided into 6 groups. C(-) was SD group, C(+) was 
group with HFD, X1 (SD treated with EL dosage 10 
mg/kg), X2 (SD treated with EL dosage 15 mg/kg), X3 
(HFD treated with EL dosage 10 mg/kg), X4 (HFD 
treated with EL dosage 15 mg/kg). 
Treatment was ethanolic or water extract of 
Eurycoma longifolia Jack, and outcome were sICAM-
1 and eNOS levels. High fat diet fed composition 
were additional cholesterol 2%, cholic acid 0.2%, and 
pig oil 5%. This the highest fat diet compotition 
confeed PARS 200 gram, yolk of quail egg, 
cholesterol 8 gram, cholic acid 0.8 gram, pig oil 40 
ml, water 51.2 ml. Total of high fat diet was 40 
gram/rat. Before treatment, rats have been adapted for 
7 days, observed for healthy condition and was 
weighted, and then randomly were alocated into 6 
groups. Body weight was evaluated every week. Each 
rat was treated in the separate plastic cage. Every day, 
researcher scaled the rat’s feed to know the intake of 
rat/ day. During treatment, rat was given high fat diet 
feed and extract Eurycoma longifolia Jack dosage 10 
mg/kg BW and 15 mg/kg BW until 60days treatments 
by force feeding (oral). 
 
RESULTS 
ICAM-1 
The highest level of ICAM-1 in the group SD was 
found in X2 group and followed by negative control 
and X1 group. The highest level of sICAM-1 in the 
HFD groups was the positive control group followed 
by X3 and X4 groups (Graph 1.). Normality test 
showed that the distribution level of sICAM-1 in each 
group was normally distributed including negative 
control (p = 0.200), X2 group (p = 0.091), positive 
control (p = 0.200), and X4 group (p = 0.144) and not 
normally distributed in the X1 and X3 group (p = 
0.003 and p = 0.001), respectively. The homogeneity 
test with Kruskall Wallis test showed that the group 
was not homogen (p = 0.023). The test showed that 
no significant difference among groups (p = 0.087). 
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Table 1. Mann Whitney U test Level of sICAM-1 
Group 
Median 
(min – 
Max) 
pg/ml 
p  value 
Pos X1 X2 X3 X4 
Neg 
(1689.40 – 
15109.48) 
0.056 0.548 0.548 0.548 0.841 
Pos 
(-491.36 – 
2863.66) 
 0.016* 0.310 0.095 0.056 
X1 
(11.89 – 
3199.16) 
  0.056 0.421 0.421 
X2 
(347.39 – 
12928.72) 
   0.151 0.310 
X3 
(-155.86 – 
14606.23) 
    0.310 
X4 
(179.64 – 
6050.93) 
     
 
 sICAM-1 levels of X1 and X2 groups were not 
different than those of negative control group (p = 
0.548 and p = 0.548).  By comparing of positive and 
negative control, it was found sICAM-1 level of 
positive control was nearly significantly lower than 
negative control control (p = 0.056). There was no 
different result observed between sICAM-1 level of 
X3 group than positive control group (p = 0.095), 
however sICAM-1 levels of X4 group was nearly 
significantly lower than positive control (p = 0.056). 
Additionally sICAM-1 levels of both X3 and X4 
groups were comparable to that of negative control (p 
= 0.548 and p = 0.841) (Table 1). 
 
eNOS 
Circulating eNOS level of X1 and X2 was higher 
than negative control group. Interestingly, eNOS level 
on positive control group was higherthan negative 
control group. Those e NOS level on X3 and X4 were 
below detectable level i.e. lower than either positive 
or control (Graph 2.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normality test performed in every group studied 
showed that eNOS level was normally distributed (p> 
0.05). These were SD groups negative control (p = 
0.053), X1 (p = 0.200) were normally distributed, 
however X2 group was not normally distributed (p = 
0.010). These were also observed in groups with HFD 
including positive control (p = 0.193), X3 group 
treated with 10 mg/kg BW/day EL(p = 0.200) and X4 
group treated with 15 mg/kg BW/day EL (p = 0.200) 
normally distributed. Test homogeneity showed that 
the groups are not homogen (p = 0.000). Kruskall 
Wallis test showed significant difference among six 
group studied (p = 0.033). The Mann Whitney U test 
indicate the different between groups in these study 
(Table 2). 
The control negative group was not significance 
different than control positive, group II, group III, and 
group IV (p = 0.841; p = 0.310; p = 0.056; p = 0.095), 
respectively. The group I showed significant different 
with negative control, group III and group IV (p = 
0.032; p = 0.008; and p = 0.008), respectively. The 
positive control showed that no significant different 
than group I, group II, group III, and group IV (p = 
0.690; p = 0.310; p = 0.095; and p = 0.151), 
respectively. 
 
Table 2. Post Hoc Analyses of eNOS 
 
DISCUSSION 
The aim of study was observing the effect of root 
extract of Eurycoma longifolia in reduces sICAM-1 
and eNOS levels of Sprague Dawley rat with high fat 
diet. This study was done to further explore of the 
Groups 
Median 
(Min – 
Max) 
pg/ml 
p value 
Pos X1 X2 X3 X4 
Neg 
(-30.84 – 
4732.55) 
0.841 0.032* 0.310 0.056 0.095 
Pos 
(-30.84 – 
649.65) 
 0.690 0.310 0.095 0.151 
X1 
(552.44 – 
2205.04) 
  0.151 0.008* 0.008* 
X2 
(-614.11 – 
48892.76) 
   0.690 0.690 
X3 
(-614.11 – 
260.80) 
    0.841 
X4 
(-516.90 – 
552.44) 
     
Figure 1. Level of sICAM-1 
(Control (-): SD, X1: SD treated with EL dosage 10 
mg/kg ; X2: SD treated with EL dosage 15 mg/kg; 
Control (+): HFD; X3: HFD treated with EL dosage 10 
mg/kg; X4: HFD treated with EL dosage 15 mg/kg) 
Figure 2. Mean level of eNOS 
(Control (-): SD, X1: SD treated with EL dosage 10 
mg/kg ; X2: SD treated with EL dosage 15 mg/kg; 
Control (+): HFD; X3: HFD treated with EL dosage 10 
mg/kg; X4: HFD treated with EL dosage 15 mg/kg) 
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mechanism used by EL in protecting vascular 
endothelial cells in HFD individual. EL effect on 
sICAM and eNOS levels were observed in rats 
receiving a combination of EL and HFD for two 
months period. Endothelial NOS that is commonly 
expressed in endothelial cells, has many favorable 
effects, including maintaining vascular dilatation, 
influencing blood pressure, vasoprotectitive and anti-
atherosclerosis development and progression.19 
This study showed that the EL can not reduce 
levels of ICAM-1 of Sprague Dawley rat that have 
been fed by HFD. The serum ICAM-1 levels of 
negative controls receiving normal diet were not 
different than the positive controls receiving HFD. 
The HFD may not be sufficient or may not have been 
feed for a sufficient duration to induce changes in 
ICAM-1 concentration. The previous study which 
used baboon as the model of animal showed that high 
cholesterol of high fat on ICAM-1 did not significant 
change during 7 weeks period.20 
This study showed that the eNOS levels of 
negative control consuming SD only were lower than 
those of receiving HFD. The eNOS concentrations 
were significantly lower by consuming HFD for 7 
weeks period.20 These findings were supported by 
studies conducted on mice receiving high-fat diets 
that showed decreased eNOS expression in the liver, 
heart and medulla kidney.21 The HFD mice used in 
this study were confirmed as animal models of 
atherosclerosis exhibited by the presence of foam 
cells in the aortic wall.22 The reduced circulating 
eNOS levels observed in HFD mice may involve the 
formation of foam cells because the presence of eNOS 
is capable of preventing the formation of decay 
cells.23 The formation of foam cells, occurs after 
macrophages take OxLDL.24 OxLDL has the ability to 
inhibit eNOS activity.25 Several other factors may 
explain the decrease in eNOS production in HFD 
mice. TNF-α may be one of the contributing factors in 
eNOS level decline. Studies using similar HFD mice 
showed an increase in the number of cells expressing 
TNF-α significantly.26 TNF-α reduces the rate of 
eNOS mRNA from endothelial cells of human 
coronary arteries.27 The HFD rat model for 
atherosclerosis shows reduced production of eNOS. 
The regulation of eNOS expression induced by 
mechanical forces, other stimuli has been shown to 
modulate the expression of eNOS mRNA in vitro. 
Most of these stimuli have been implicated in vascular 
pathophysiology, and they include other mechanical 
forces, cell growth, cytokines, lipoproteins, growth 
factors, and oxidative stress. Changes in eNOS 
mRNA expression and cell ability to produce NO are 
generally in the order of two to threefold. Although 
this modulation level may seem simple, it should be 
remembered that small changes in NO levels may 
have significant physiological effects. In the case of 
vascular relaxation, the dose response to NO is quite 
steep; small increases in NO concentrations resulted 
in major changes in vascular tone.28 Recent research 
has provided a more detailed understanding of the 
molecular mechanisms involved in eNOS expression 
modulation. 
Although EL treatment has no significant different 
on ICAM-1, but EL with a dose of 15 mg / kg is lower 
than EL at a dose of 10 mg / kg. Many bioactive 
compounds have been isolated from E. longifolia, 
such as quassinoid, canthine-6-one alkaloids, β-
carbolin alkaloids, squalene derivatives, 
triterpenestirucallane, biphenylneolignans, phenolic 
compounds, and bioactive steroids. Through a 
bioguided isolation approach, it has recently identified 
several inhibitors of the NF-κB transcription factor 
(the kappa-light core factor of activated B cells) at the 
root of E. longifolia.29 One of the most interesting 
compounds appears to be Eurycoma 
lactonequassinoid C-19. The transcription factor NF-
κB is a central performer in the inflammatory 
response that regulates, for example, the expression of 
endothelial adhesion molecules, such as VCAM-1, 
ICAM-1, or E-selectin, which is essential in 
inflammatory initiation since adhesion molecules 
promote extravasation of leucocytes to the site of 
injury.30 NF-κB signaling pathways are activated in 
response to pro-inflammatory cytokines such as TNFα 
or other pro-inflammatory stimuli, such as 
lipopolysaccharide (LPS).31 NF The family of 
transcription factors consists of five transcription 
factor proteins (p65 (RelA), c -Rel, RelB, p50, and 
p52) which are usually found as homo or heterodimer. 
In most cell types, the prevalent retained p65 / p50 
heterodimer is inactivated in the cytoplasm by closing 
the sequence of nuclear localization by one of several 
kB protein inhibitors (IκB), which IκBα is a 
prototypical member.31 Pro-inflammatory stimulation 
induces a signal cascade which causes the 
phosphorylation of IκB kinase (IKK) in the activation 
loop (Ser177 and Ser181). The phosphorylated IKK 
complex in turn phosphorylates IκB to mark 
degradation through the 26S proteasome. 
The results of this study also show that EL does 
not affect the eNOS level. However, the level of 
eNOS in group IV is higher than in group III. The E. 
longifolia water extract increases the expression of 
NOS to form NO and also inhibits PDE3, PDE4 and 
PDE5. It is known to be involved in a myriad of 
biochemical processes in the human body including 
smooth muscle relaxation.32 Thippeswamy & Marris 
reported that NO produced by nNOS induced cGMP 
synthesis. Penile eruption is a proven androgen-
dependent NO-mediated process. In penile erection, 
NO places its target molecule from guanylylcyclase 
that dissolves on the smooth muscle surface of the 
corpus cavernosum and causes a conformational 
change in the enzyme leading to increased production 
of a 3'-5'-cylic messenger guanosine. monophosphate 
(cGMP) of guanosine triphosphate (GTP). cGMP 
induces relaxation of smooth muscle in the corpus 
cavernosum and allows blood to flow into the penis 
where it becomes trapped. The degradation and loss 
of cGMP from smooth muscle tissue causes 
contraction and normal blood flow in and out of the 
corpora cavernosa. PDE5 is dominant in the penis, 
breaking cGMP into GMP by catalyzing the reaction 
that damages the phosphodiester bond33. E. longifolia 
helps maintain high levels of cGMP in the corpora 
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cavernosa by pressing PDE5 to break down cGMP. 
Inhibition of PDE5 increases the duration of cGMP 
remain in smooth muscle tissue thus increasing.33 
 
CONCLUSION 
No significant difference on level of ICAM-1 was 
found among groups with or without HFD treatment. 
Significant difference on the level of eNOS was found 
among groups with or without HFD treatment. 
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